Zobrazeno 1 - 10
of 27
pro vyhledávání: ''
Autor:
Chris Hunter, Manish Chand, Gina Brown, Jemma Bhoday, Paris Tekkis, Aurelie Garant, Te Vuong, Constantinos Simillis, Giovanni Artho, Al Mutaz Abulafi, Muhammed R. S. Siddiqui, Shahnawaz Rasheed
Publikováno v:
British Journal of Cancer
background: Pathological extramural vascular invasion (EMVI) is an independent prognostic factor in rectal cancer, but can also be identified on MRI-detected extramural vascular invasion (mrEMVI). We perform a meta-analysis to determine the risk of m
Autor:
Anna Heeney, David Gibbons, Desmond C. Winter, Kieran Sheahan, Alessandro Lugli, Giacomo Puppa, Ailín C. Rogers
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Vol. 115, No 7 (2016) pp. 831-840
Rogers, A C; Winter, D C; Heeney, A; Gibbons, D; Lugli, Alessandro; Puppa, G; Sheahan, K (2016). Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. British journal of cancer, 115(7), pp. 831-840. Nature Publishing Group 10.1038/bjc.2016.274
British Journal of Cancer, Vol. 115, No 7 (2016) pp. 831-840
Rogers, A C; Winter, D C; Heeney, A; Gibbons, D; Lugli, Alessandro; Puppa, G; Sheahan, K (2016). Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. British journal of cancer, 115(7), pp. 831-840. Nature Publishing Group 10.1038/bjc.2016.274
BACKGROUND Tumour budding is a histological finding in epithelial cancers indicating an unfavourable phenotype. Previous studies have demonstrated that it is a negative prognostic indicator in colorectal cancer (CRC), and has been proposed as an addi
Autor:
Nolan B. Condron, Michael A. Liu, Jane A. Driver, Gregory A. Abel, Martha Wadleigh, Tammy T. Hshieh
Publikováno v:
British Journal of Cancer
Background: Few studies have investigated the relationship between physician and patient-assessed performance status (PS) in blood cancers. Methods: Retrospective analysis among 1418 patients with haematologic malignancies seen at Dana-Farber Cancer
Publikováno v:
British Journal of Cancer
Barrett's oesophagus (BE) is the premalignant condition associated with the development of oesophageal adenocarcinoma (OAC). Diagnostically, p53 immunohistochemistry remains the only biomarker recommended clinically to aid histopathological diagnosis
Autor:
Shivshankari Rajkumar, Ian R. Watson
Publikováno v:
British Journal of Cancer
Large-scale genomic analyses of cutaneous melanoma have revealed insights into the aetiology and heterogeneity of this disease, as well as opportunities to further personalise treatment for patients with targeted and immune therapies. Herein, we revi
Publikováno v:
British Journal of Cancer
Ovarian cancer is the fifth leading cause of female cancer deaths in the Western world. Significant progress has been made in the treatment of patients with ovarian cancer, however, the majority of patients experience disease recurrence and new thera
Autor:
Leslie Samuel, Edwin Amalraj Raja, R. Robertson, Lewis D Ritchie, Amanda J Lee, David H. Brewster, Neil C Campbell, Peter Murchie, Nicola J. Gray
Publikováno v:
British Journal of Cancer
Background: British 5-year survival from colorectal cancer (CRC) is below the European average, but the reasons are unclear. This study explored if longer provider delays (time from presentation to treatment) were associated with more advanced stage
Publikováno v:
British Journal of Cancer
Background:In the United Kingdom, breast cancer incidence is lower in South Asian and Black women than in White women, but the extent to which this is due to known risk factors is unknown. In a large prospective study, we describe breast cancer incid
Autor:
Yi Tzu Lee, Tzeng Ji Chen, Shu-Chen Kuo, Yu Wen Hu, Chang-Phone Fung, Te-Li Chen, Yin-Yin Chen, Chia Jen Liu
Publikováno v:
British Journal of Cancer
Background: In addition to lung cancers, tuberculosis infections have been associated with increased risk of non-pulmonary malignancies in case reports. Our population-based study employed standardized incidence ratios (SIRs) to systemically survey n
Autor:
Guru Sonpavde, Toni K. Choueiri
Publikováno v:
British Journal of Cancer
Despite recent advances, metastatic renal cell carcinoma remains largely an incurable disease. Vascular endothelial growth factor and mammalian target of rapamycin inhibitors have provided improvements in clinical outcomes. High-dose interleukin 2 re